Natural Capsules Revises Preferential Allotment Terms

Equity Issue: 1,12,500 shares at Rs 178; Convertible Warrants: 4,50,000 units at Rs 178.
Reader Takeaway: Promoter-led capital infusion follows regulatory clarification; remains subject to shareholder approval at September 9 EGM.

What just happened

Natural Capsules Ltd has dispatched a formal corrigendum regarding its Extra-Ordinary General Meeting (EGM) scheduled for September 9, 2026. The filing modifies the specific terms of a preferential allotment of equity shares and convertible warrants initially approved by the board on August 12, 2026. This administrative update follows specific queries raised by the BSE and NSE regarding the proposal.

Why this matters

The revision ensures compliance with regulatory standards for preferential issues. The company is seeking to raise approximately Rs 10.01 crore through this transaction. By issuing shares and warrants to promoter Sunil Laxminarayan Mundra at Rs 178 per unit, the firm is strengthening its capital base for immediate operational requirements and growth initiatives.

What changes now

The pricing structure remains consistent at Rs 178 per share or warrant. The funds are earmarked for specific usage: 90% of the equity proceeds are dedicated to working capital, while the entire Rs 8.01 crore raised via warrants is also directed toward working capital needs. Shareholders will now vote on these revised terms at the EGM in September.

Context metrics

The convertible warrants carry an 18-month exercise period, requiring a 25% upfront payment. The company has included a Practicing Company Secretary’s certification to confirm adherence to SEBI ICDR regulations, providing transparency to retail and institutional stakeholders.

What to track next

Investors should monitor the outcome of the EGM vote and subsequent filings regarding the actual allotment of these shares and warrants to the promoter.